Forest Laboratories Inc. (FRX): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Forest Laboratories ( FRX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Forest Laboratories rose $1.30 (1.3%) to $99.55 on average volume. Throughout the day, 3,478,239 shares of Forest Laboratories exchanged hands as compared to its average daily volume of 3,215,000 shares. The stock ranged in a price between $98.13-$99.67 after having opened the day at $98.42 as compared to the previous trading day's close of $98.25. Other companies within the Health Care sector that increased today were: InterMune ( ITMN), up 170.8%, DARA Biosciences ( DARA), up 23.1%, Genocea Biosciences ( GNCA), up 21.1% and Sunesis Pharmaceuticals ( SNSS), up 17.5%.

Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. Forest Laboratories has a market cap of $26.3 billion and is part of the drugs industry. Shares are up 63.7% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Forest Laboratories a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Forest Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, Aoxing Pharmaceutical Company ( AXN), down 16.0%, Vivus ( VVUS), down 13.2%, Tenet Healthcare ( THC), down 9.1% and Star Scientific ( STSI), down 8.8% , were all laggards within the health care sector with WellPoint ( WLP) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump